Rena Hirani Awarded the Inaugural James Isbister Prize at the Blood ISBT 2025
Rena Hirani, Senior Research Fellow at the Australian Red Cross Lifeblood, shared on LinkedIn:
”Following a big week of wins, I am thrilled to share yet more exciting news.
I was awarded the inaugural James Isbister Prize at the recent Blood ISBT 2025 Conference in Perth.
This honour marks a significant milestone in my research career, and I’m deeply grateful for the recognition.
Professor James Isbister is a pioneering figure in haematology, transfusion medicine and medical education.
His work shaped global standards in patient blood management.
Prof. Isbister completed his postgraduate training in internal medicine at St Vincent’s Hospital.
He was part of a team that performed the first successful Australian allogeneic bone marrow transplants, which is now commonly used to treat blood cancers.
Transfusion medicine became his passion since every speciality involves blood.
This prize, named after him in honour of his achievements to Australian medicine, was awarded for significant contributions in research into blood and blood products, education of the medical community and encouragement of appropriate clinical use of blood and plasma products for better healthcare.
The occasion was made even more memorable by the fact that James, energetically in his 80s, was present to award me personally which was a deeply meaningful honour.
I would also like to recognise the long term support of my work by Australian Red Cross Lifeblood, ANZSBT and National Blood Authority, Australia.
It is a true privilege to be a part of the transfusion community.”
More winner stories featured in Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome